BioCryst Offering Pressure (BCRX)

Posted in pre-market 
November 20th, 2009

BioCryst Pharmaceuticals, Inc. (BCRX) is active and lower on a secondary offering.  The company sold 5 million shares in a secondary offering at $9.75 per share via Morgan Stanley, JPMorgan, and Oppenheimer.  At 8:22 AM EST we have shares down almost 6% at $9.81 on 87,000 shares.  The average daily volume is $almost 3 million shares and the 52-week trading range is $0.85 to $13.47.

JON OGG

Comments are closed

-->